High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association?
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Raised adiponectin is associated with increased rather than decreased risk of cardiovascular disease (CVD) and mortality at older age. We examined whether N-terminal pro-brain natriuretic peptide (NT-proBNP), a marker of cardiac dysfunction, may help explain this relationship. METHODS AND RESULTS: A prospective study of 2879 men aged 60–79 years with no history of CVD at baseline followed-up for a mean of 9 years during which there were 196 major coronary heart disease events (fatal and non-fatal myocardial infarction) and 667 deaths (including 225 CVD deaths), whereas adiponectin concentration was inversely associated with several conventional CVD risk factors; it was significantly and positively associated with NT-proBNP concentration. After adjustment for several vascular risk factors, including renal function and muscle mass, relative risks associated with a top third versus bottom third comparison of adiponectin concentration were 1.51 (1.02–2.23) for coronary heart disease, 1.67 (1.15–2.41) for CVD mortality and 1.41 (1.13–1.95) for all cause mortality. Upon further adjustment for NT-proBNP, these relative risks attenuated to 1.31 (0.88–1.94), 1.31 (0.90–1.91) and 1.26 (1.01–1.59), respectively. CONCLUSION: We show for the first time that concomitantly elevated NT-proBNP concentration, at least, partially explains the apparently positive relationship between adiponectin concentration and risk of CVD and mortality in asymptomatic elderly men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Adiponectin: action, regulation and association to insulin sensitivity
Lihn, A. S., Pedersen, S. B., & Richelsen, B. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00159.x · Cited by 660
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
Wannamethee, S. G., Lowe, G. D. O., Whincup, P. H., Rumley, A., Walker, M., & Lennon, L. (2002) · Circulation · doi:10.1161/01.cir.0000016346.14762.71 · Cited by 487
Self-citationWannamethee, S. G., Shaper, A. G., Lennon, L., & Whincup, P. H. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1339 · Cited by 307 · cited 1×
“3142* (triceps skinfold thickness), was used as an indicator of muscle mass.(26) Prevalent diabetes included men with a diagnosis of diabetes or men with fasting blood glucose 7mmol/l.”
MethodSelf-citationFrystyk, J., Berne, C., Berglund, L., Jensevik, K., Flyvbjerg, A., & Zethelius, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1067 · Cited by 201
Adiponectin and Coronary Heart Disease: The Strong Heart Study
Lindsay, R. S., Resnick, H. E., Zhu, J., Tun, M. L., Howard, B. V., Zhang, Y., Yeh, J., & Best, L. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000153090.21990.8c · Cited by 169 · cited 1×
“Population-based prospective studies have typically reported modest, inverse associations between circulating adiponectin levels and coronary heart disease (CHD), although some have shown no or weak associations.(7,8) By contrast, studies based in high-risk populations(9) and in older people have reported positive ass…”
BackgroundKoenig, W., Khuseyinova, N., Baumert, J., Meisinger, C., & Löwel, H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.053 · Cited by 166
Serum Adiponectin and Coronary Heart Disease Risk in Older Black and White Americans
Kanaya, A. M., Wassel Fyr, C., Vittinghoff, E., Havel, P. J., Cesari, M., Nicklas, B., Harris, T., Newman, A. B., Satterfield, S., Cummings, S. R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0107 · Cited by 71
Cited by
Adipokines as novel biomarkers and regulators of the metabolic syndrome
Deng, Y., & Scherer, P. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05875.x · Cited by 558
Hao, G., Li, W., Guo, R., Yang, J.-G., Wang, Y., Tian, Y., Liu, M.-Y., Peng, Y.-G., & Wang, Z.-W. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.018 · Cited by 82
“It is important to improve the understanding of this issue for both public health and clinical practice who aim to reduce CVD occurrence [5,6].”
BackgroundMethodInfluentialAdiponectin, type 2 diabetes and cardiovascular risk
Lindberg, S., Jensen, J. S., Bjerre, M., Pedersen, S. H., Frystyk, J., Flyvbjerg, A., Galatius, S., Jeppesen, J., & Mogelvang, R. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487313514894 · Cited by 66
Menzaghi, C., Xu, M., Salvemini, L., De Bonis, C., Palladino, G., Huang, T., Copetti, M., Zheng, Y., Li, Y., Fini, G., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0130-y · Cited by 40
Metadata
- Authors
- Wannamethee, S. G., Welsh, P., Whincup, P. H., Sawar, N., Thomas, M. C., Gudnarsson, V., & Sattar, N.
- Venue
- European Journal of Cardiovascular Prevention & Rehabilitation
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05
- Volume
- 18
- Issue
- 1
- Pages
- 65-71
- ISSN
- 1741-8267 (ISSN-L)
- OpenAlex
- W1970435801
- Cited by
- 71
- References
- 8
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.